|
|||||
|
|
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates |
|
| Authors: | David G. McLaren Seongah Han Beth Ann Murphy Larissa Wilsie Steven J. Stout Haihong Zhou Thomas P. Roddy Judith N. Gorski Daniel E. Metzger Myung K. Shin Dermot F. Reilly Heather H. Zhou Marija Tadin-Strapps Steven R. Bartz Anne-Marie Cumiskey Thomas H. Graham Dong-Ming Shen Karen O. Akinsanya Shirly Pinto |
| Affiliation: | 1. Division of Cardio Metabolic Disease, Merck & Co., Inc., Kenilworth, NJ 07033, USA;2. Pharmacology, Merck & Co., Inc., Kenilworth, NJ 07033, USA;3. Genetics and Pharmacogenomics, Merck & Co., Inc., Boston, MA 02115, USA;4. Business Development and Licensing, Merck & Co., Inc., Kenilworth, NJ 07033, USA;5. Discovery Chemistry, Merck & Co., Inc., Kenilworth, NJ 07033, USA |
| Abstract: |  |
| Keywords: | DGAT2 DGAT1 dyslipidemia triglyceride VLDL apolipoprotein B non-human primate translational research |
| 本文献已被 ScienceDirect 等数据库收录！ | |